表紙
市場調査レポート

バイオバーデン検査の世界市場 2019年:製品別 (検査装置、消耗品)・試験項目別 (好気性菌、嫌気性菌、真菌、芽胞)・用途別 ・エンドユーザー別の将来予測

Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019

発行 MarketsandMarkets 商品コード 330568
出版日 ページ情報 英文 146 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
バイオバーデン検査の世界市場 2019年:製品別 (検査装置、消耗品)・試験項目別 (好気性菌、嫌気性菌、真菌、芽胞)・用途別 ・エンドユーザー別の将来予測 Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019
出版日: 2015年05月14日 ページ情報: 英文 146 Pages
概要

世界のバイオバーデン検査市場は、2014年には3億5440万米ドル、2019年には5億6560万米ドルの規模に達し、またその間の年平均成長率 (CAGR) は9.8%と予測されています。市場成長の主な促進要因として、医療機器産業の成長や、製薬・バイオテクノロジー産業の傾向の変化、食の安全性への不安の拡大、ライフサイエンス分野への研究開発 (R&D) 投資の拡大、微生物汚染による製品リコール件数の増加などが挙げられます。他方、検査装置のコストの高さや複雑性、厳格な規制、承認までの時間の長さなどが市場成長率を抑制する要因となっています。現在は北米が世界最大の市場ですが、アジア太平洋地域も急速に追いつきつつあります。

当レポートでは、全世界のバイオバーデン検査 (汚染微生物数検査) の市場について分析し、市場の基本的構造や最新動向、主な市場促進・阻害要因、市場規模の動向見通し (今後6年間分)、製品別・検査の種類別・用途別・エンドユーザー別・地域別の詳細動向、市場競争の状態、今後の技術開発・市場発展の方向性、主要企業のプロファイルなどを調査・考察しております。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場のダイナミクス
    • 促進要因
      • 医療機器・製薬・バイオテクノロジー産業の成長
      • 食品・飲料の安全性に関する懸念の増大
      • 微生物汚染による製品リコール件数の増加
      • ライフサイエンス分野での活発な研究開発 (R&D) 投資の動き
      • 医療産業の発達と医療費の増大
    • 抑制要因
      • 微生物計数装置の価格の高さ
    • 機会
      • 医薬品製造受託機関 (CMO) 市場の機会
      • 新興国市場
    • 課題
      • 知的・熟練人材の不足
      • 試験装置・消耗品に対する厳格な規制政策

第6章 産業考察

  • ポーターのファイブフォース分析
  • 戦略的ベンチマーキング

第7章 バイオバーデン測定市場:製品別

  • イントロダクション
  • 消耗品
    • 培養培地・試薬・キット
    • その他の消耗品
  • 試験器具
    • PCR (ポリメラーゼ連鎖反応)
    • 顕微鏡
    • 自動微生物同定システム
    • その他の器具

第8章 バイオバーデン測定市場:検査の種類別

  • イントロダクション
  • 好気性菌数
  • 嫌気性菌数
  • 真菌/モールド数
  • 芽胞値

第9章 バイオバーデン測定市場:用途別

  • イントロダクション
  • 原材料試験
  • 医療機器試験
  • 中間製品の検査
  • 滅菌バリデーション試験
  • 設備の洗浄バリデーション

第10章 バイオバーデン測定市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 医療機器メーカー
  • 医薬品製造受託機関 (CMO)
  • 食品・飲料および農産品メーカー
  • 微生物試験機関

第11章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア
  • その他の地域 (RoW)

第12章 競合情勢

  • 概要
  • 競合状況・動向
    • 企業買収
    • 新製品・サービスの発売
    • 事業拡張
    • その他

第13章 企業プロファイル

  • イントロダクション
  • Charles River Laboratories International, Inc.
    • 事業概要
    • 製品・サービス
    • 最近の発展動向
    • MnMの見解
  • Sigma-Aldrich Corporation
  • SGS S.A.
  • WUXI Pharmatech (Cayman), Inc.
  • Merck & Co., Inc
  • Becton, Dickinson, and Company
  • North American Science Associates, Inc. (NAMSA)
  • Nelson Laboratories, Inc.
  • Pacific Biolabs
  • ATS Labs, Inc.

第14章 付録

図表一覧

目次
Product Code: BT 3394

The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories. The CMOs segment is expected to grow at the highest CAGR in the coming five years. Growth in this segment will be driven by the rising demand for cost-effective alternatives for manufacturing in emerging as well as developed countries.

The major factors contributing to the growth of the global bioburden testing market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the bioburden testing market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make necessary decisions regarding product offerings, geographical focus, change in strategic approach, and R&D investments for innovations in products and technologies and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the bioburden testing market. The report analyzes the market by product, test type, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the bioburden testing market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the bioburden testing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various bioburden testing products across regions
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the bioburden testing market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency
  • 1.5. Limitations
  • 1.6. Market Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Breakdown & Data Triangulation
  • 2.3. Key Data From Secondary Sources
  • 2.4. Key Data From Primary Sources
  • 2.5. Key Industry Insights
  • 2.6. Assumptions for the Study

3. Executive Summary

4. Premium Insights

  • 4.1. Bioburden Testing Market, By Product
  • 4.2. Bioburden Testing Market, for Instruments
  • 4.3. Bioburden Testing Market, By Test Types
  • 4.4. Bioburden Testing Market, By Applications
  • 4.5. Geographic Snapshot
  • 4.6. Bioburden Testing Market, By End Users

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Bioburden Testing Market By Product
    • 5.2.2. Bioburden Testing Market By Test Type
    • 5.2.3. Bioburden Testing Market By Application
    • 5.2.4. Bioburden Testing Market By End User
    • 5.2.5. Bioburden Testing Market By Region
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Growing Medical Device, Pharmaceutical and Biotechnology Industries
      • 5.3.1.2. Increasing Food & Beverage Safety Concerns
      • 5.3.1.3. Increasing Product Recall Due to Microbial Contamination
      • 5.3.1.4. Strong Trend of R&D Investments in Life Sciences
      • 5.3.1.5. Growing Healthcare Industry and Medical Spending
    • 5.3.2. Restrain
      • 5.3.2.1. High Costs of Microbial Enumeration Instruments
    • 5.3.3. Opportunities
      • 5.3.3.1. Opportunity in Contract Manufacturing Market
      • 5.3.3.2. Emerging Economies
    • 5.3.4. Challenges
      • 5.3.4.1. Shortage of Knowledgeable and Skilled Professionals
      • 5.3.4.2. Stringent Regulatory Policies for Instruments and Consumables

6. Industry Insights

  • 6.1. Porter's Five Forces Analysis
    • 6.1.1. Threat From New Entrants
    • 6.1.2. Threat From Substitutes
    • 6.1.3. Bargaining Power of Suppliers
    • 6.1.4. Bargaining Power of Buyers
    • 6.1.5. Intensity of Competitive Rivalry
  • 6.2. Strategic Benchmarking

7. Bioburden Testing Market, By Product

  • 7.1. Introduction
  • 7.2. Consumables
    • 7.2.1. Culture Media, Reagents & Kits
    • 7.2.2. Other Consumables
  • 7.3. Instruments
    • 7.3.1. PCR
    • 7.3.2. Microscopes
    • 7.3.3. Automated Microbial Identification Systems
    • 7.3.4. Other Instruments

8. Bioburden Testing Market, By Test Type

  • 8.1. Introduction
  • 8.2. Aerobic Count
  • 8.3. Anaerobic Count
  • 8.4. Fungi / Mold Count
  • 8.5. Spore Count

9. Bioburden Testing Market, By Application

  • 9.1. Introduction
  • 9.2. Raw Materials Testing
  • 9.3. Medical Devices Testing
  • 9.4. In-Process Material Testing
  • 9.5. Sterilization Validation Testing
  • 9.6. Equipment Cleaning Validation

10. Bioburden Testing Market, By End User

  • 10.1. Introduction
  • 10.2. Pharmaceutical & Biotechnology Companies
  • 10.3. Medical Device Manufacturers
  • 10.4. Contract Manufacturing Organizations (CMOS)
  • 10.5. Manufacturers of Food & Eberage and Agriculture Products
  • 10.6. Microbial Testing Laboratories

11. Geographic Analysis

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
  • 11.4. Asia
  • 11.5. Rest of the World (RoW)

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Competitive Situation and Trends
    • 12.2.1. Acquisitions
    • 12.2.2. New Product and Service Launches
    • 12.2.3. Expansion
    • 12.2.4. Others

13. Company Profiles

  • 13.1. Introduction
  • 13.2. Charles River Laboratories International, Inc.
    • 13.2.1. Business Overview
    • 13.2.2. Products & Services
    • 13.2.3. Recent Developments
    • 13.2.4. MnM View
  • 13.3. Sigma-Aldrich Corporation
    • 13.3.1. Business Overview
    • 13.3.2. Products & Services
    • 13.3.3. Recent Developments
    • 13.3.4. MnM View
  • 13.4. SGS S.A.
    • 13.4.1. Business Overview
    • 13.4.2. Services
    • 13.4.3. Recent Developments
    • 13.4.4. MnM View
  • 13.5. WUXI Pharmatech (Cayman), Inc.
    • 13.5.1. Business Overview
    • 13.5.2. Services
    • 13.5.3. Recent Developments
    • 13.5.4. MnM View
  • 13.6. Merck & Co., Inc.
    • 13.6.1. Business Overview
    • 13.6.2. Products & Services
    • 13.6.3. Recent Developments
    • 13.6.4. MnM View
  • 13.7. Becton, Dickinson, and Company
    • 13.7.1. Business Overview
    • 13.7.2. Product & Services
    • 13.7.3. Key Strategy
    • 13.7.4. Recent Developments
  • 13.8. North American Science Associates, Inc. (NAMSA)
    • 13.8.1. Business Overview
    • 13.8.2. Services
    • 13.8.3. Key Strategy
    • 13.8.4. Recent Developments
  • 13.9. Nelson Laboratories, Inc.
    • 13.9.1. Business Overview
    • 13.9.2. Services
    • 13.9.3. Key Strategy
    • 13.9.4. Recent Developments
  • 13.10. Pacific Biolabs
    • 13.10.1. Business Overview
    • 13.10.2. Service Portfolio
    • 13.10.3. Key Strategy
    • 13.10.4. Recent Developments
  • 13.11. ATS Labs, Inc.
    • 13.11.1. Business Overview
    • 13.11.2. Services
    • 13.11.3. Key Strategy
    • 13.11.4. Recent Developments

14. Appendix

List of Tables

  • Table 1: Growing Medical Device, Pharmaceutical and Biotechnology Industries Propelling the Growth of the Bioburden Testing Market
  • Table 2: High Costs of Microbial Enumeration Instruments to Hinder Market Growth
  • Table 3: Contract Manufacturing to Create New Growth Opportunities for Market
  • Table 4: Shortage of Knowledgeable and Skilled Professionals A Major Challenge for the Market
  • Table 5: Microbial Limit Testing Market Size, By Product 2012-2019 ($Million)
  • Table 6: Market Size for Consumables, By Type, 2012-2019 ($Million)
  • Table 7: Microbial Limit Testing Market Size for Consumables, By Region, 2012-2019 ($Million)
  • Table 8: North America: Market Size for Consumables, By Country, 2012-2019 ($Million)
  • Table 9: Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
  • Table 10: North America: Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
  • Table 11: Market Size for Other Consumables, By Region, 2012-2019 ($Million)
  • Table 12: North America: Market Size for Other Consumables, By Country, 2012-2019 ($Million)
  • Table 13: Bioburden Testing Market Size for Instruments, By Type, 2012-2019 ($Million)
  • Table 14: Market Size for Instruments, By Region, 2012-2019 ($Million)
  • Table 15: North America: Market Size for Instruments, By Country, 2012-2019 ($Million)
  • Table 16: Microbial Limit Testing Market Size for PCR, By Region, 2012-2019 ($Million)
  • Table 17: North America: Bioburden Testing Market Size for PCR, By Country, 2012-2019 ($Million)
  • Table 18: Market Size for Microscopes, By Region, 2012-2019 ($Million)
  • Table 19: North America: Bioburden Testing Market Size for Microscopes, By Country, 2012-2019 ($Million)
  • Table 20: Market Size for Automated Microbial Identification System, By Region, 2012-2019 ($Million)
  • Table 21: North America: Bioburden Testing Market Size for Automated Microbial Identification System, By Country, 2012-2019 ($Million)
  • Table 22: Market Size for Other Instruments, By Region, 2012-2019 ($Million)
  • Table 23: North America: Bioburden Testing Market Size for Other Instruments, By Country, 2012-2019 ($Million)
  • Table 24: Market Size, By Test 2012-2019 ($Million)
  • Table 25: Microbial Limit Testing Market Size for Aerobic Count, By Region, 2012-2019 ($Million)
  • Table 26: North America: Market Size for Aerobic Count, By Country, 2012-2019 ($Million)
  • Table 27: Bioburden Testing Market Size for Anaerobic Count, By Region, 2012-2019 ($Million)
  • Table 28: North America: Bioburden Testing Market Size for Anaerobic Count, By Country, 2012-2019 ($Million)
  • Table 29: Market Size for Fungi/Mold Count, By Region, 2012-2019 ($Million)
  • Table 30: North America: Microbial Limit Testing Market Size for Fungi/Mold Count, By Country, 2012-2019 ($Million)
  • Table 31: Market Size for Spore Count, By Region, 2012-2019 ($Million)
  • Table 32: North America: Bioburden Testing Market Size for Spore Count, By Country, 2012-2019 ($Million)
  • Table 33: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 34: Market Size for Raw Materials Testing, By Region, 2012-2019 ($Million)
  • Table 35: North America: Market Size for Raw Materials Testing, By Country, 2012-2019 ($Million)
  • Table 36: Market Size for Medical Devices Testing, By Region, 2012-2019 ($Million)
  • Table 37: North America: Bioburden Testing Market Size for Medical Devices Testing, By Country, 2012-2019 ($Million)
  • Table 38: Microbial Limit Testing Market Size for In-Process Testing, By Region, 2012-2019 ($Million)
  • Table 39: North America: Bioburden Testing Market Size for In-Process Testing, By Country, 2012-2019 ($Million)
  • Table 40: Microbial Limit Testing Market Size for Sterilization Validation Testing, By Region, 2012-2019 ($Million)
  • Table 41: North America: Market Size for Sterilization Validation Testing, By Country, 2012-2019 ($Million)
  • Table 42: Bioburden Testing Market Size for Equipment Cleaning Validation, By Region, 2012-2019 ($Million)
  • Table 43: North America: Market Size for Equipment Cleaning Validation , By Country, 2012-2019 ($Million)
  • Table 44: Bioburden Testing Market Size, By End User 2012-2019 ($Million)
  • Table 45: Microbial Limit Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Region, 2012-2019 ($Million)
  • Table 46: North America: Bioburden Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Country, 2012-2019 ($Million)
  • Table 47: Market Size for Medical Device Manufacturers, By Region, 2012-2019 ($Million)
  • Table 48: North America: Bioburden Testing Market Size for Medical Device Manufacturers, By Country, 2012-2019 ($Million)
  • Table 49: Market Size for CMOS, By Region, 2012-2019 ($Million)
  • Table 50: North America: Bioburden Testing Market Size for CMOS, By Country, 2012-2019 ($Million)
  • Table 51: Market Size for Manufacturers of Food & beverage and Agriculture Products, By Region, 2012-2019 ($Million)
  • Table 52: North America: Microbial Limit Testing Market Size for Manufacturers of Food & beverage and Agriculture Products, By Country, 2012-2019 ($Million)
  • Table 53: Market Size for Microbial Testing Labs, By Region, 2012-2019 ($Million)
  • Table 54: North America: Bioburden Testing Market Size for Microbial Testing Labs, By Country, 2012-2019 ($Million)
  • Table 55: Market Size, By Region 2012-2019 ($Million)
  • Table 56: North America: Microbial Limit Testing Market Size, By Country 2012-2019 ($Million)
  • Table 57: North America: Market Size, By Product 2012-2019 ($Million)
  • Table 58: North America: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 59: North America: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 60: North America: Market Size, By Test 2012-2019 ($Million)
  • Table 61: North America: Market Size, By Application 2012-2019 ($Million)
  • Table 62: North America: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 63: U.S.: Market Size, By Product 2012-2019 ($Million)
  • Table 64: U.S.: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 65: U.S.: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 66: U.S.: Market Size, By Test 2012-2019 ($Million)
  • Table 67: U.S.: Market Size, By Application 2012-2019 ($Million)
  • Table 68: U.S.: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 69: Canada: Market Size, By Product 2012-2019 ($Million)
  • Table 70: Canada: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 71: Canada: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 72: Canada: Market Size, By Test 2012-2019 ($Million)
  • Table 73: Canada: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 74: Canada: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 75: Europe: Market Size, By Product 2012-2019 ($Million)
  • Table 76: Europe: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 77: Europe: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 78: Europe: Microbial Limit Testing Market Size, By Test 2012-2019 ($Million)
  • Table 79: Europe: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 80: Europe: Market Size, By End User 2012-2019 ($Million)
  • Table 81: Asia: Market Size, By Product 2012-2019 ($Million)
  • Table 82: Asia: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 83: Asia: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 84: Asia: Market Size, By Test 2012-2019 ($Million)
  • Table 85: Asia: Market Size, By Application 2012-2019 ($Million)
  • Table 86: Asia: Market Size, By End User 2012-2019 ($Million)
  • Table 87: RoW: Market Size, By Product 2012-2019 ($Million)
  • Table 88: RoW: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 89: RoW: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 90: RoW: Market Size, By Test 2012-2019 ($Million)
  • Table 91: RoW: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 92: RoW: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 93: Recent Acquisitions
  • Table 94: Recent Product and Service Launches
  • Table 95: Recent Expansion
  • Table 96: Recent Other Strategies

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Top-Down Approach
  • Figure 3: Bottom-Up Approach
  • Figure 4: Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 5: Bioburden Testing Market Snapshot, By Product (2014 vs. 2019): Consumables Segment to Dominate the Market During the Forecast Period
  • Figure 6: Market Snapshot, By Test (2014 vs. 2019): Aerobic Count Segment to Witness Highest Growth
  • Figure 7: Market Snapshot, By Application (2014 vs. 2019): Raw Material Testing Segment is Dominant in the Market
  • Figure 8: Pharmeceutical and Biotechnology Companies Held the Largest Share of the Bioburden Testing Market in 2014
  • Figure 9: Global Market, By Region, 2014: North America Accounted for the Largest Share While Asia is Expected to Grow at A Highest CAGR From 2014-2019
  • Figure 10: Consumables Offers Attractive Market Opportunities
  • Figure 11: PCR Segment to Grow at Highest CAGR
  • Figure 12: Culture Media, Reagents and Kits Segment to Grow at Highest CAGR
  • Figure 13: Aerobic Count to Grow at Highest CAGR
  • Figure 14: Raw Material Testing to Account for the Largest Share of the Market
  • Figure 15: Asia to Dominate Bioburden Testing Market
  • Figure 16: Pharmaceutical Companies & Biotechnology Companies Offer Highest Growth Opportunities
  • Figure 17: Bioburden Testing Market Segmentation By Product
  • Figure 18: Market Segmentation By Test Type
  • Figure 19: Market Segmentation By Application
  • Figure 20: Market Segmentation By End User
  • Figure 21: Market Segmentation By Region
  • Figure 22: Growing Medical Device, Pharmaceutical and Biotechnology Industries to Fuel Market Growth
  • Figure 23: Porter's Five Forces Analysis
  • Figure 24: Strategic Benchmarking: Top Players Adopted Acquisitions as Key Growth Strategies
  • Figure 25: Consumables Market to Witness Significant Growth in the Forecast Period
  • Figure 26: Asia to Record the Highest Growth Rate in the Consumables Market
  • Figure 27: Asia Will Grow at Highest CAGR in the Forecast Period 2015-2019
  • Figure 28: Raw Materials Testing Segment to Witness Growth in the Forecast Period
  • Figure 29: CMOS are Expected Grow at the Highest CAGR
  • Figure 30: Asian Market for Bioburden Testing is Expected to Grow at Highest Rate From 2014 to 2019
  • Figure 31: Asia: High Demand for Veterinary Software From End Users
  • Figure 32: North America: Market Snapshot
  • Figure 33: Major Players Adopted Acquisitions and New Product and Service Launches as A Key Growth Strategy Between 2012 and 2014
  • Figure 34: Market Evolution Framework: Acquisitions and Product and Service Launches Fuelled Market Growth
  • Figure 35: Acquisitions, New Product and Service Launches Were Preferred Strategies for Market Players
  • Figure 36: Geographic Revenue Mix of Top 4 Market Players
  • Figure 37: Charles River Laboratories International, Inc.: Company Snapshot
  • Figure 38: Sigma-Aldrich Corporation: Company Snapshot
  • Figure 39: SGS SA: Company Snapshot
  • Figure 40: WUXI Pharmatech (Cayman) Inc.: Company Snapshot
  • Figure 41: Merck & Co., Inc.: Company Snapshot
  • Figure 42: Becton, Dickinson and Company: Company Snapshot
  • Figure 43: North American Science Associates, Inc.: Company Snapshot
  • Figure 44: Nelson Laboratories Inc.: Company Snapshot
  • Figure 45: Pacific Biolabs: Company Snapshot
  • Figure 46: ATS Labs, Inc.: Company Snapshot
Back to Top